QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 craig-hallum-initiates-coverage-on-delcath-systems-with-buy-rating-announces-price-target-of-18

Craig-Hallum analyst Chase Knickerbocker initiates coverage on Delcath Systems (NASDAQ:DCTH) with a Buy rating and announces...

 hc-wainwright--co-maintains-buy-on-delcath-systems-raises-price-target-to-22

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Delcath Systems (NASDAQ:DCTH) with a Buy and raises the pri...

 wall-street-trades-flat-on-mixed-producer-inflation-meme-stocks-see-wild-ride-bitcoin-drops-whats-driving-markets-tuesday

Wall Street is experiencing a subdued trading session, with all major indices showing minimal movement around midday in New York.

 stephens--co-initiates-coverage-on-delcath-systems-with-overweight-rating-announces-price-target-of-25

Stephens & Co. analyst Sudan Loganathan initiates coverage on Delcath Systems (NASDAQ:DCTH) with a Overweight rating and...

 delcath-systems-announces-publication-of-results-from-pivotal-focus-study-in-metastatic-uveal-melanoma-patients-treated-with-hepzato-kit

Significantly Higher Overall Response Rate vs Meta-analysis of Historical Controls (36.3% vs. 5.5%)Other Efficacy Endpoints Inc...

 netflix-to-rally-over-15-here-are-10-top-analyst-forecasts-for-wednesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

 hc-wainwright--co-maintains-buy-on-delcath-systems-raises-price-target-to-20

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Delcath Systems (NASDAQ:DCTH) with a Buy and raises the pri...

 delcath-systems-q4-gaap-eps-048-beats-051-estimate-sales-53900k-miss-54000k-estimate

Delcath Systems (NASDAQ:DCTH) reported quarterly losses of $(0.48) per share which beat the analyst consensus estimate of $(0.5...

 earnings-scheduled-for-march-26-2024

Companies Reporting Before The Bell • bluebird bio (NASDAQ:BLUE) is likely to report quarterly loss at $0.66 per share on reve...

 earnings-preview-delcath-systems
Earnings Preview: Delcath Systems
03/25/2024 15:02:11

 delcath-systems-names-martha-s-rook-as-coo

She joins Delcath from insitro where she served as a Chief Technical Operations Officer and was responsible for core research s...

 delcath-systems-announces-healthcare-setting-locator-for-hepzato-kit-melphalanhepatic-delivery-system-on-the-hepzatokitcom-website

Delcath Systems, Inc. (NASDAQ:DCTH), an interventional oncology company focused on the treatment of primary and metastatic canc...